The University Hospital of Zürich is one of five university hospitals in Switzerland. The first hospital in Zürich, from which the current hospital derives, is recorded as having existed as early as 1204. The name, location and buildings have since changed many times.

During the past decade, University Hospital Zurich, Division of Cardiology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Zurich, Division of Cardiology" #1 collaborator was "Asklepios Kliniken Hamburg GmbH" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Cardiocentro Ticino" with 1 trials as a collaborator, "Catholic University of the Sacred Heart" with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Zurich, Division of Cardiology" are "Coronary Artery Disease" (2 trials), "Healthy" (2 trials), "Heart Failure" (2 trials), "Aortic Stenosis" (1 trials) and "Heart Failure，Congestive" (1 trials). Many other conditions were trialed in "University Hospital Zurich, Division of Cardiology" in a lesser frequency.

Most popular intervention types in "University Hospital Zurich, Division of Cardiology" are "Drug" (5 trials), "Other" (3 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Dapagliflozin" (1 trials), "Diclofenac" (1 trials), "Immediate complete PCI" (1 trials) and "No intervention will be done. The study is observational" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Zurich, Division of Cardiology" are 14 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Zurich, Division of Cardiology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University Hospital Zurich, Division of Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Zurich, Division of Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".